drugset / Trial / NCT04670809

Safety and Efficacy Study of Clevidipine Butyrate Injection in Hypertensive Emergencies

NCT04670809

Phase 3 Unknown 262 enrolled Nanjing Yoko Biomedical Co., Ltd.
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study was to determine the efficacy and safety of clevidipine for treating Hypertensive emergencies(defined as systolic blood pressure \>180 mmHg and/or diastolic blood pressure \>120 mmHg, accompanied by acute organ damage).

Timeline

Start
2020-07-27
Primary completion
2021-08
Completion
2021-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Clevidipine Small molecule 2 mg Intravenous
Comparator Nicardipine Small molecule 0.5 ug/kg Intravenous

Indications